DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Lencioni R, Llovet JM, Han G.
Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): Phase II, randomized, double-blind SPACE trial.
J Clin Oncol 2012;
30 (Suppl. 04) abstr LBA154^
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.